The Valley Desk

Clinical trial reportClinical lung cancerPublished

Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Chester County Hospital, Fox Chase Cancer Center, University of Pennsylvania, with Penn Medicine, Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Clinical lung cancer
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Carboplatin; Proto-Oncogene Proteins; Antineoplastic Combined Chemotherapy Protocols; Smoke; Mutation; Protein-Tyrosine Kinases; Antibodies, Monoclonal, Humanized; ErbB Receptors; Bevacizumab
PubMed ID
37451930
PubMed Central ID
PMC11476834
Added to directory
Source checked

Report a correction or request removal